Compare SANM & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SANM | CRL |
|---|---|---|
| Founded | 1980 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.0B |
| IPO Year | 1993 | 2000 |
| Metric | SANM | CRL |
|---|---|---|
| Price | $161.14 | $218.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $120.00 | ★ $193.17 |
| AVG Volume (30 Days) | ★ 626.8K | 626.8K |
| Earning Date | 01-30-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.07 | N/A |
| EPS | ★ 4.46 | N/A |
| Revenue | ★ $8,128,382,000.00 | $4,023,704,000.00 |
| Revenue This Year | $75.74 | N/A |
| Revenue Next Year | $12.92 | $1.68 |
| P/E Ratio | $34.40 | ★ N/A |
| Revenue Growth | ★ 7.40 | N/A |
| 52 Week Low | $63.67 | $91.86 |
| 52 Week High | $178.39 | $222.37 |
| Indicator | SANM | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 73.39 |
| Support Level | $146.47 | $208.67 |
| Resistance Level | $165.90 | $222.37 |
| Average True Range (ATR) | 6.39 | 5.37 |
| MACD | 0.29 | 1.10 |
| Stochastic Oscillator | 78.26 | 87.24 |
Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.